Calimmune completes $15M Series B financing
Calimmune Inc., a clinical-stage gene therapy company, has successfully completed its $15 million Series B financing round, led by a large pharmaceutical company. Alexandria Venture Investments also joined with existing…
![](https://azbigmedia.com/wp-content/uploads/2015/05/calimmube-300x175.jpg)